Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Exp Cell Res ; 318(13): 1508-16, 2012 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-22504005

RESUMEN

Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of kidney failure and characterized by the formation of multiple fluid-filled cysts in the kidneys. It is believed that environmental factors may play an important role in the disease progression. However, the molecular identity of autocrine/paracrine factors influencing cyst formation is largely unknown. In this study, we identified transforming growth factor-ß2 (TGF-ß2) secreted by normal human kidney (NHK) and ADPKD cells as an inhibitor of cystogenesis in 3D culture system using ADPKD cells from human kidneys. TGF-ß2 was identified in conditioned media (CM) of NHK and ADPKD cells as a latent factor activated by heat in vitro. While all TGF-ß isoforms recombinant proteins (TGF-ß1, -ß2, or -ß3) displayed a similar inhibitory effect on cyst formation, TGF-ß2 was the predominant isoform detected in CM. The involvement of TGF-ß2 in the suppression of cyst formation was demonstrated by using a TGF-ß2 specific blocking antibody and a TGF-ß receptor I kinase inhibitor. TGF-ß2 inhibited cyst formation by a mechanism other than activation of p38 mitogen-activated protein (MAP) kinase that mediated cell death in ADPKD cells. Further, we found that TGF-ß2 modulated expression of various genes involved in cell-cell and cell-matrix interactions and extracellular matrix proteins that may play a role in the regulation of cystogenesis. Collectively, our results suggest that TGF-ß2 secreted by renal epithelial cells may be an inhibitor of cystogenesis influencing the progression of ADPKD.


Asunto(s)
Riñón Poliquístico Autosómico Dominante/metabolismo , Factor de Crecimiento Transformador beta2/metabolismo , Anticuerpos Bloqueadores/farmacología , Proliferación Celular , Células Cultivadas , Medios de Cultivo Condicionados , Progresión de la Enfermedad , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Células Epiteliales/patología , Expresión Génica , Humanos , Riñón/citología , Riñón/efectos de los fármacos , Riñón/metabolismo , Riñón Poliquístico Autosómico Dominante/genética , Riñón Poliquístico Autosómico Dominante/patología , Riñón Poliquístico Autosómico Dominante/prevención & control , Inhibidores de Proteínas Quinasas/farmacología , Proteínas Serina-Treonina Quinasas/antagonistas & inhibidores , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptor Tipo I de Factor de Crecimiento Transformador beta , Receptores de Factores de Crecimiento Transformadores beta/antagonistas & inhibidores , Proteínas Recombinantes/farmacología , Factor de Crecimiento Transformador beta2/antagonistas & inhibidores , Factor de Crecimiento Transformador beta2/genética , Factor de Crecimiento Transformador beta2/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA